Data Collection of the PASCAL (Pattern Scan Laser) Photocoagulator for the Treatment of Clinically Significant Macular Edema. PASCAL 1

Who is the sponsor?

Who are the patients?
Patients with non-proliferative diabetic retinopathy who have clinically significant macular edema.

How long are the eligible patients enrollment?
One year follow up.

When did participation agreement start at our site?
Summer 2008

What is the enrollment goal for the sponsor?
5 patients

Is the enrollment still open?
No. Enrollment closed. Follow up only.

What is this study investigating?
To collect and evaluate data for the use of the PASCAL laser for the treatment of clinically significant macular edema in patients with non-proliferative diabetic retinopathy.

How is the treatment administered?
Focal laser photocoagulation is applied according to guidelines set forth in the Early Treatment of Diabetic Retinopathy Study.